Sana Biotechnology (SANA) Equity Ratio (2020 - 2026)

Sana Biotechnology's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.32 for Q1 2026.

• In Q1 2026, Equity Ratio fell 32.0% year-over-year to 0.32; the TTM figure through Mar 2026 stood at 0.32 (down 32.0% YoY), while the FY2025 annual figure was 0.39, down 22.82% from the prior year.
• Equity Ratio came in at 0.32 for Q1 2026 at Sana Biotechnology, down from 0.39 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.67 in Q1 2022 to a low of 0.32 in Q1 2026.
• A 5-year average of 0.52 and a median of 0.52 in 2024 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio climbed 9.35% in 2024 and slumped 38.27% in 2025, its largest moves.
• Sana Biotechnology's Equity Ratio stood at 0.61 in 2022, then slipped by 16.2% to 0.51 in 2023, then dropped by 1.69% to 0.5 in 2024, then dropped by 22.82% to 0.39 in 2025, then retreated by 17.29% to 0.32 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.32, 0.39, and 0.45 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison